This finding was further validated by TCGA data, which revealed significant overexpression of ITGAV in CHOL, colorectal cancer (COAD), ESCA, glioblastoma multiforme (GBM), HNSC, LIHC, LUAD, LUSC, STAD, and THCA (Fig. 1B). This evidence concerns the gene ITGAV and colorectal cancer.